Intracellular neutralization of a virus using a cell-penetrating molecular transporter.

Autor: Sapparapu G; The Vanderbilt Vaccine Center, Nashville, TN 37232, USA. james.crowe@vanderbilt.edu., Sims AL, Aiyegbo MS, Shaikh FY, Harth EM, Crowe JE Jr
Jazyk: angličtina
Zdroj: Nanomedicine (London, England) [Nanomedicine (Lond)] 2014 Aug; Vol. 9 (11), pp. 1613-24. Date of Electronic Publication: 2013 Nov 06.
DOI: 10.2217/nnm.13.139
Abstrakt: Aims: Antibodies are the principal mediator of immunity against reinfection with viruses. Antibodies typically neutralize viruses by binding to virion particles in solution prior to attachment to susceptible cells. Once viruses enter cells, conventional antibodies cannot inhibit virus infection or replication. It is desirable to develop an efficient and nontoxic method for the introduction of virus-inhibiting antibodies into cells.
Materials & Methods: In this article, we report a new method for the delivery of small recombinant antibody fragments into virus-infected cells using a dendrimer-based molecular transporter.
Results & Conclusion: The construct penetrated virus-infected cells efficiently and inhibited virus replication. This method provides a novel approach for the immediate delivery of inhibitory antibodies directed to virus proteins that are exposed only in the intracellular environment. This approach circumvents the current and rather complicated expression of inhibitory antibodies in cells following gene transfer.
Databáze: MEDLINE